Feature|Articles|October 10, 2023
Catalent's Flexible Fill/Finish Capabilities for Drug Products CPHI Barcelona
Author(s)BioPharm International Editors
Catalent provides fill/finish services across a range of product formats from clinical to commercial scale.
From sites in the U.S. and Europe, Catalent provides drug product development and manufacturing services, leveraging proven expertise from pre-clinical to commercial launch and supply of small molecules, biologics, vaccines, and biosimilars. Catalent has extensive experience with drug product process development across a variety of liquid and lyophilized formulations into vials, syringes and cartridges. Our facilities and high-speed filling lines offer aseptic processing that is flexible, fast, and integrated with secondary packaging.
URL:
ㅤ
CPHI Barcelona 2023
Booth 3N50
Stop by the Catalent Stand for a Taste of Spain networking reception taking place on Wednesday, October 25, 2023 from 4:30PM-6:30PM.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
5
